Northern Trust Corp Vaxart, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Vaxart, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 375,751 shares of VXRT stock, worth $308,115. This represents 0.0% of its overall portfolio holdings.

Number of Shares

375,751

Previous 363,700 3.31%

Holding current value

$308,115

Previous $472,000 46.82%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.53 - $1.3 $6,387 - $15,666	12,051 Added 3.31%	375,751 $251,000
Q1 2024 May 14, 2024	BUY	$0.56 - $1.41 $16,556 - $41,686	29,565 Added 8.85%	363,700 $472,000
Q4 2023 Feb 13, 2024	BUY	$0.57 - $0.85 $39,011 - $58,174	68,441 Added 25.76%	334,135 $190,000
Q3 2023 Nov 13, 2023	BUY	$0.69 - $0.85 $19,045 - $23,461	27,602 Added 11.59%	265,694 $199,000
Q2 2023 Aug 11, 2023	SELL	$0.6 - $1.41 $531,162 - $1.25 Million	-885,271 Reduced 78.81%	238,092 $173,000
Q1 2023 May 15, 2023	BUY	$0.71 - $1.25 $30,559 - $53,802	43,042 Added 3.98%	1,123,363 $853,000
Q4 2022 Feb 13, 2023	SELL	$0.75 - $2.24 $45,639 - $136,308	-60,852 Reduced 5.33%	1,080,321 $1.04 Million
Q3 2022 Nov 14, 2022	SELL	$2.09 - $4.5 $43,018 - $92,623	-20,583 Reduced 1.77%	1,141,173 $2.49 Million
Q2 2022 Aug 12, 2022	SELL	$2.7 - $5.28 $93,063 - $181,991	-34,468 Reduced 2.88%	1,161,756 $4.07 Million
Q1 2022 May 13, 2022	SELL	$4.29 - $6.64 $154,122 - $238,548	-35,926 Reduced 2.92%	1,196,224 $6.03 Million
Q4 2021 Feb 08, 2022	BUY	$5.77 - $7.96 $139,922 - $193,030	24,250 Added 2.01%	1,232,150 $7.73 Million
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $149,708 - $219,961	-22,445 Reduced 1.82%	1,207,900 $9.6 Million
Q2 2021 Aug 13, 2021	BUY	$5.06 - $10.78 $2.5 Million - $5.32 Million	493,135 Added 66.89%	1,230,345 $9.22 Million
Q1 2021 May 12, 2021	BUY	$5.64 - $23.33 $8,522 - $35,251	1,511 Added 0.21%	737,210 $4.46 Million
Q4 2020 Feb 11, 2021	BUY	$3.5 - $7.98 $91,402 - $208,397	26,115 Added 3.68%	735,699 $4.2 Million
Q3 2020 Nov 16, 2020	BUY	$4.78 - $16.97 $505,986 - $1.8 Million	105,855 Added 17.53%	709,584 $4.72 Million
Q2 2020 Aug 14, 2020	BUY	$1.68 - $8.85 $870,547 - $4.59 Million	518,183 Added 605.74%	603,729 $5.34 Million
Q1 2020 May 14, 2020	BUY	$0.34 - $2.87 $29,085 - $245,517	85,546 New	85,546 $152,000

Others Institutions Holding VXRT

# of Institutions

108

Shares Held

40.6M

Call Options Held

96.7K

Put Options Held

239K

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $104M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Vaxart, Inc. Transaction History